Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New E. coli cloning vector using a cellulase gene (celA) as a screening marker.

S J Jang1, W J Park, S K Chung

  • 1Kyung Hee University, Suwon, Korea.

Biotechniques
|December 4, 2001
PubMed
Summary

This study introduces a new cloning system for E. coli using the cellulase gene (celA) as a screening marker. This method efficiently identifies recombinant transformants by detecting the absence of halos on cellulose agar plates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 116, 122301 (2016)].

Physical review letters·2025
Same author

mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.

Journal of autoimmunity·2023
Same author

Publisher Correction: Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.

Nature metabolism·2023
Same author

Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.

Nature metabolism·2023
Same author

Adiponectin gene therapy for Alzheimer disease in a mouse model: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2021
Same author

Small molecule of adiponectin receptor agonist-AdipoRon-for Alzheimer disease: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2020

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Microbial Genetics

Background:

  • Traditional cloning vectors often rely on the beta-galactosidase system for screening, which can present ambiguities.
  • Efficient screening methods are crucial for identifying successful recombinant DNA insertions in bacterial hosts.

Purpose of the Study:

  • To develop a novel screening marker for E. coli cloning vectors using the extracellular endoglucanase A (celA) gene.
  • To create and characterize new cloning vectors (pCEL series) with multiple cloning sites within the celA gene.

Main Methods:

  • Isolated a 1.4-kb EcoRI fragment containing the celA gene from Clostridium thermocellum.
  • Cloned the celA fragment into a modified pUC18 vector, replacing the beta-galactosidase gene fragment.
  • Constructed pCEL series vectors with varying multiple cloning sites within celA.

Related Experiment Videos

  • Screened for recombinant transformants on cellulose agar plates, observing halo formation as an indicator of functional CelA.

    • Main Results:

    • Recombinant transformants with foreign DNA insertions into the celA multiple cloning sites showed no clear halos on cellulose agar.
    • This celA-based screening system demonstrated over 90% efficiency in identifying recombinant transformants with foreign DNA inserts.
    • The pCEL series vectors successfully transformed various E. coli strains, irrespective of alpha-complementation mutations.
    • The system proved effective across all E. coli strains due to the absence of an endogenous cellulase gene.

    Conclusions:

    • The celA gene serves as an effective and unambiguous screening marker for E. coli cloning vectors.
    • The developed pCEL vectors offer an efficient, convenient, and cost-effective alternative to existing cloning systems.
    • This novel screening system simplifies the identification of recombinant clones, enhancing molecular cloning workflows.